1. Home
  2. BBNX vs QNST Comparison

BBNX vs QNST Comparison

Compare BBNX & QNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • QNST
  • Stock Information
  • Founded
  • BBNX 2015
  • QNST 1999
  • Country
  • BBNX United States
  • QNST United States
  • Employees
  • BBNX N/A
  • QNST N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • QNST Business Services
  • Sector
  • BBNX Health Care
  • QNST Consumer Discretionary
  • Exchange
  • BBNX Nasdaq
  • QNST Nasdaq
  • Market Cap
  • BBNX 967.6M
  • QNST 923.2M
  • IPO Year
  • BBNX 2025
  • QNST 2010
  • Fundamental
  • Price
  • BBNX $22.26
  • QNST $15.27
  • Analyst Decision
  • BBNX Strong Buy
  • QNST Buy
  • Analyst Count
  • BBNX 10
  • QNST 6
  • Target Price
  • BBNX $26.10
  • QNST $27.33
  • AVG Volume (30 Days)
  • BBNX 1.2M
  • QNST 474.4K
  • Earning Date
  • BBNX 11-06-2025
  • QNST 11-03-2025
  • Dividend Yield
  • BBNX N/A
  • QNST N/A
  • EPS Growth
  • BBNX N/A
  • QNST N/A
  • EPS
  • BBNX N/A
  • QNST 0.08
  • Revenue
  • BBNX $78,022,000.00
  • QNST $1,093,711,000.00
  • Revenue This Year
  • BBNX $42.80
  • QNST $10.72
  • Revenue Next Year
  • BBNX $34.58
  • QNST $9.66
  • P/E Ratio
  • BBNX N/A
  • QNST $190.88
  • Revenue Growth
  • BBNX 550.45
  • QNST 78.27
  • 52 Week Low
  • BBNX $8.89
  • QNST $14.27
  • 52 Week High
  • BBNX $26.66
  • QNST $26.27
  • Technical
  • Relative Strength Index (RSI)
  • BBNX 56.75
  • QNST 39.18
  • Support Level
  • BBNX $19.07
  • QNST $15.17
  • Resistance Level
  • BBNX $21.08
  • QNST $16.39
  • Average True Range (ATR)
  • BBNX 1.44
  • QNST 0.55
  • MACD
  • BBNX -0.45
  • QNST -0.15
  • Stochastic Oscillator
  • BBNX 52.15
  • QNST 5.15

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About QNST QuinStreet Inc.

QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia.

Share on Social Networks: